BELIEVE: Phase III Study of Luspatercept vs Placebo in Beta-Thalassemia

Downloadable slideset from a workshop series from Clinical Care Options (CCO) on the expanding treatment options for hemophilia A & B

Stacy E. Croteau, MD, MMS
Program Director Guy A. Young, MD
Program Director Released: January 25, 2023

From ASCO GI 2023, preliminary safety and efficacy data from the LEAP-015 study of pembrolizumab + lenvatinib + CT for gastroesophageal cancer, as reported by Clinical Care Options (CCO)

Data from ASCO GI 2023 from the SPOTLIGHT trial of zolbetuximab + mFOLFOX6 for CLDN18.2-positive/HER2-negative gastric cancers, as reported by Clinical Care Options (CCO)

On-demand webcast of a live symposium chaired by Dr Joyce O’Shaughnessy on biomarker-guided neo/adjuvant therapy for early breast cancer, from Clinical Care Options (CCO)

Joyce O'Shaughnessy, MD Melinda Telli, MD Tiffany A. Traina, MD Physicians: maximum of 1.5 AMA PRA Category 1 Credits™ Released: January 25, 2023 Expired: January 24, 2024